ArticleThe Journal of infectious diseases2017
Expansion of Surveillance for Vaccine-preventable Diseases: Building on the Global Polio Laboratory Network and the Global Measles and Rubella Laboratory Network Platforms.
Article in The Journal of infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed.
- Japanese encephalitis: Current status, recent progress, and persistent challenges.PLoS neglected tropical diseases · 2026Review
- Global surveillance quality gaps in antimicrobial resistance monitoring: a composite-index and inequality analysis of 85 countries.JAC-antimicrobial resistance · 2026Article
- A model to target effective vaccine-preventable disease surveillance programme: Qualitative evidences from a private healthcare facility in Bhubaneswar, Odisha.Journal of family medicine and primary care · 2026Article
- A Multiplex Bead Serology Panel For Vaccine-Preventable Diseases Using Dried Blood Spots.Risk management and healthcare policy · 2025Article
- The Global Measles and Rubella Laboratory Network Supports High-Quality Surveillance.Vaccines · 2024Article
- Article
- Use of Measles and Rubella Rapid Diagnostic Tests to Improve Case Detection and Targeting of Vaccinations.Vaccines · 2024Review
- Prevalence of Non-Polio Enteroviruses in the Sewage of Guangzhou City, China, from 2013 to 2021.Microbiology spectrum · 2023Article
- A scoping review on laboratory surveillance in the WHO Southeast Asia Region: Past, present and the future.Journal of global health · 2023Article
- Assessing the impact of regional laboratory networks in East and West Africa on national health security capacities.PLOS global public health · 2023Article
- Expansion of the measles and rubella laboratory network, India.Bulletin of the World Health Organization · 2022Article
- Article
- Identifying priority challenges and solutions for COVID-19 vaccine delivery in low- and middle-income countries: A modified Delphi study.PLOS global public health · 2022Article
- The Global Landscape of Pediatric Bacterial Meningitis Data Reported to the World Health Organization-Coordinated Invasive Bacterial Vaccine-Preventable Disease Surveillance Network, 2014-2019.The Journal of infectious diseases · 2021Article
- Genomic-informed pathogen surveillance in Africa: opportunities and challenges.The Lancet. Infectious diseases · 2021Review
- The future of Japanese encephalitis vaccination: expert recommendations for achieving and maintaining optimal JE control.NPJ vaccines · 2021Article
- Development of a Measles and Rubella Multiplex Bead Serological Assay for Assessing Population Immunity.Journal of clinical microbiology · 2021Article
- Disease Surveillance Investments and Administration: Limits to Information Value in Pakistan Polio Eradication.Risk analysis : an official publication of the Society for Risk Analysis · 2021Article
- Laboratory capacity assessments in 25 African countries at high risk of yellow fever, August-December 2018.The Pan African medical journal · 2021Article
- Enhancing acute flaccid paralysis surveillance through the use of pictorial surveillance reminder cards during supplementary immunization activities, December 2014: a survey in Jigawa State, Nigeria.The Pan African medical journal · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Laboratory networks were established to provide accurate and timely laboratory confirmation of infections, an essential component of disease surveillance systems. The World Health Organization (WHO) coordinates global laboratory surveillance of vaccine-preventable diseases (VPDs), including polio, measles and rubella, yellow fever, Japanese encephalitis, rotavirus, and invasive bacterial diseases. In addition to providing high-quality laboratory surveillance data to help guide disease control, elimination, and eradication programs, these global networks provide capacity-building and an infrastructure for public health laboratories. There are major challenges with sustaining and expanding the global laboratory surveillance capacity: limited resources and the need for expansion to meet programmatic goals. Here, we describe the WHO-coordinated laboratory networks supporting VPD surveillance and present a plan for the further development of these networks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.